Clinical Trial Update: A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics [Phase 2]

View source ↗

Summary

This Phase 2 randomized, double-blind, placebo-controlled trial evaluated whether ORMD-0801 insulin capsules could affect exogenous insulin requirements in Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• ORMD-0801

Snippet

Sponsor: Oramed, Ltd. | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2017-07-06